I thought the result was OK. Realised FY2022 Group Revenue was...

I thought the result was OK.

Realised FY2022 Group Revenue was slightly below the low end of guidance, but EEG Revenue growth above +40% (which exceeded my personal expectations, even though it did receive a little boost from the exchange rate) should see Realised FY2022 Group Gross Margin within the 53%-54% range previously indicated.

Someone might not have liked the fact that they didn't provide an exact GM figure at this stage, but it is something that happened with previous quarterlies as well, and it will be clear next month anyway.

Importantly, iCap network volumes keep growing and EEG’s ASR products keep conquering market share within that market. Also, the deferral of the ~5mUS$ earn-out payment to FY2024 will afford AIM additional short-term flexibility to acquire or to increase their buy-back.